Why Organon & Co. Is A Smart Investment (NYSE:OGN)

May 8, 2023 · Why Organon & Co. Is A Smart Investment. May 08, 2023 11:41 AM ... pharmaceutical house Organon & Co. (NYSE:OGN) going ex-dividend. We own the stock since May 2021 plowing the ~5% yield, or $0.28 ...

5%
OFF

Why Organon & Co. Is A Smart Investment (NYSE:OGN)

2 weeks from now

seekingalpha.com

80%
OFF

With 80% Institutional Ownership, Organon & Co. (NYSE:OGN) Is A ...

2 weeks from now

Oct 20, 2024 · A total of 15 investors have a majority stake in the company with 50% ownership ; Analyst forecasts along with ownership data serve to give a strong idea about prospects for a …

simplywall.st

3%
OFF

Is Organon & Co's Stock (OGN) A Good Investment? | AAII

2 weeks from now

Nov 14, 2024 · Currently, Organon & Co.’s price-earnings ratio is 3.2. Organon & Co.’s trailing 12-month revenue is $6.4 billion with a 20.3% profit margin. Year-over-year quarterly sales growth …

aaii.com

63%
OFF

Organon Stock Is Still Worth A Look (NYSE:OGN) - Seeking Alpha

2 weeks from now

Feb 24, 2024 · A quarter has passed since I initiated a "Buy" rating on Organon & Co. (NYSE:OGN). In this time the stock has gained around 63% - that's 7 times more than the …

seekingalpha.com

$27.00
OFF

Organon Stock Maintains Hold Rating From TD Cowen As …

2 weeks from now

Oct 7, 2024 · On Monday, TD Cowen sustained its Hold rating on Organon & Co. (NYSE:OGN) with a consistent price target of $27.00. The firm highlighted Organon's unique strategy and …

investing.com

$4.47
OFF

Organon (OGN) Upgraded To Strong Buy: What Does It Mean For …

2 weeks from now

Jul 24, 2024 · Earnings Estimate Revisions for Organon For the fiscal year ending December 2024, this pharmaceutical company is expected to earn $4.47 per share, which is a change of …

nasdaq.com

FAQs about Why Organon & Co. Is A Smart Investment (NYSE:OGN) Coupon?

Is Organon (OGN) a good stock to buy?

Organon (OGN) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over the past month, shares of this pharmaceutical company have returned -4.7%, compared to the Zacks S&P 500 composite's -2.4% change. ...

Who owns Organon & co (OGN) stock?

Only 1.40% of the stock of Organon & Co. is held by insiders. 77.43% of the stock of Organon & Co. is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Read more about Organon & Co.'s insider trading history. Receive OGN Stock News and Ratings via Email ...

Is Organon & co a good investment?

Why Organon & Co. Is A Smart Investment The share price of Organon & Co. has taken a dramatic tumble after reporting quarters with sluggish revenue and earnings numbers. The dividend is holding at about a 5% yield and its safety seems of only slight concern because the company has strong cash flow. ...

Why is Organon so cheap?

Beyond its debt and the fact that it isn’t growing at breakneck speed in a world where many investors are chasing hypergrowth, it’s hard to say why Organon is so cheap. One reason could be that it is a spinoff. Spinoffs are often poorly understood by the market and don’t always find their footing with investors right away. ...

Is Organon a good stock to buy in 2025?

Although there’s confidence in the future sales of Nexplanon and Vtama, with the latter expected to drive significant growth, the revenue projections remain moderate. Additionally, Organon’s potential headwinds in 2025, such as the loss of exclusivity for Atozet and maturing biosimilar assets, contribute to a cautious outlook. ...

Did Organon (OGN) offer fertile ground for investors?

simonkr/E+ via Getty Images In May, I believed that shares of Organon (NYSE:OGN)offered fertile ground for investors. Shares of the business have been pressured since the spin-off from Merck (MRK)amidst elevated debt, poor working capital conversion and fallingmargins. ...